A phase I‐II trial of the combination of recombinant leukocyte a interferon and recombinant human interferon‐γ in patients with metastatic malignant melanoma

Edward T. Creagan, Charles L. Loprinzi, David L. Ahmann, Daniel J. Schaid

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Fingerprint

Dive into the research topics of 'A phase I‐II trial of the combination of recombinant leukocyte a interferon and recombinant human interferon‐γ in patients with metastatic malignant melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences